Moreover, it has been shown that levels of serum TNF-α, IL-2, and serum CD44 (sCD44) are all increased in NHL and correlate with tumor burden, the presence of symptoms, and other clinical and laboratory variables [46,47]. The gene discussed is TNF; the disease is non-Hodgkin lymphoma.